Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and Viremia

zalcitabine has been researched along with Viremia in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's12 (66.67)18.2507
2000's3 (16.67)29.6817
2010's2 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amancha, PK; Ansari, AA; Hong, JJ; Rogers, K; Villinger, F1
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M1
Domínguez Castellanos, A; Justo Alpañés, E; Orbea Ríos, L1
Carruth, LM; Clements, JE; Li, M; Mankowski, JL; Miller, MD; Queen, LA; Shen, A; Siliciano, RF; Tarwater, PM; Zink, MC1
Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J1
Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC1
Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C1
Bonino, F; d'Urso, N; Ponzetto, A; Zahm, FE1
Bürgisser, P; Meylan, PR; Pagani, JL; Spertini, F; Weyrich-Suter, C1
Brizzi, M; Ceccherini-Nelli, L; Forastieri, G; Iuliano, R; Mazzotta, F; Mecocci, L1
Autran, B; Blanc, C; Carcelain, G; Debré, P; Katlama, C; Leibowitch, J; Li, TS; Mathez, D; Tubiana, R1
Blanchard, G; Blum, L; Calvo, F; Danne, O; Lebbé, C; Morel, P; Pellet, C; Vérola, O1
Arrizabalaga, J; Clotet, BG; Cruceta, A; Dalmau, D; Gallart, T; García, F; Gatell, JM; Gomez-Sirvent, JL; Grau, I; Knobel, H; Miró, JM; O'Brien, WA; Podzamczer, D; Pumarola, T; Romeu, J; Sambeat, MA1
Albrecht, H; Hufert, FT; Lauer, J; Racz, P; Schneider, C; Stellbrink, HJ; Tenner-Racz, K; van Lunzen, J1
Cheng, YC; Chevallier, M; Guerret, S; Hantz, O; Jamard, C; King, I; Le Guerhier, F; Peyrol, S; Pichoud, C; Trépo, C; Zoulim, F1
Japour, AJ1
Chang, HE1
Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Quackenbush, SL; Strobel, JD; Zeidner, NS1

Trials

4 trial(s) available for zalcitabine and Viremia

ArticleYear
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
    AIDS (London, England), 1995, Volume: 9, Issue:12

    Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine

1995
Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.
    The Journal of infectious diseases, 1997, Volume: 175, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopsy, Needle; CD4 Lymphocyte Count; CD4-CD8 Ratio; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; HIV-1; Humans; Lymph Nodes; Polymerase Chain Reaction; Regression Analysis; RNA Splicing; RNA, Viral; Saquinavir; Single-Blind Method; Viremia; Zalcitabine; Zidovudine

1997
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Science (New York, N.Y.), 1997, Jul-04, Volume: 277, Issue:5322

    Topics: Adult; Anti-HIV Agents; Antigens, Viral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Homeostasis; Humans; Immunologic Memory; Lymphocyte Activation; Lymphocyte Count; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Tuberculin; Viral Load; Viremia; Zalcitabine; Zidovudine

1997
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Palatine Tonsil; Ritonavir; RNA, Viral; Spain; Stavudine; Viremia; Zalcitabine; Zidovudine

1999

Other Studies

14 other study(ies) available for zalcitabine and Viremia

ArticleYear
In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit.
    Journal of immunology (Baltimore, Md. : 1950), 2013, Dec-15, Volume: 191, Issue:12

    Topics: Adenine; Animals; Anti-Retroviral Agents; Antibodies, Monoclonal; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation, Preclinical; Emtricitabine; Histocompatibility Antigens Class I; Immunity, Cellular; Immunoglobulin Fc Fragments; Immunotherapy; Lymphokines; Macaca mulatta; Organophosphonates; Programmed Cell Death 1 Receptor; Recombinant Proteins; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Solubility; Tenofovir; Viremia; Zalcitabine

2013
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine

2012
[Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; Depression; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Mononucleosis; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Refusal; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Viremia; Zalcitabine; Zidovudine

2002
SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy.
    Journal of medical primatology, 2005, Volume: 34, Issue:3

    Topics: Adenine; Animals; Anti-Retroviral Agents; Drug Therapy, Combination; Emtricitabine; Immunity, Cellular; Interferon-gamma; Linear Models; Macaca nemestrina; Organophosphonates; Primate Diseases; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes; Tenofovir; Viremia; Zalcitabine

2005
Viral dynamics in hepatitis B virus infection.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-30, Volume: 93, Issue:9

    Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine

1996
Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma.
    The Journal of infectious diseases, 1996, Volume: 174, Issue:2

    Topics: Antiviral Agents; Biopsy; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lymph Nodes; RNA, Viral; Viremia; Zalcitabine; Zidovudine

1996
Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP).
    Liver, 1996, Volume: 16, Issue:2

    Topics: Animals; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA, Viral; Drug Carriers; Female; Hepatitis B; Hepatitis B Virus, Woodchuck; Male; Marmota; Serum Albumin; Viremia; Virus Replication; Zalcitabine

1996
Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Apr-15, Volume: 14, Issue:5

    Topics: Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; RNA, Viral; Stavudine; Viral Load; Viremia; Virus Replication; Zalcitabine; Zidovudine

1997
Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Viral Load; Viremia; Zalcitabine; Zidovudine

1998
Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2.
    Antiviral therapy, 1998, Volume: 3, Issue:4

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Interleukin-2; Kinetics; Lymphoid Tissue; Male; Middle Aged; RNA, Viral; Saquinavir; Viremia; Zalcitabine; Zidovudine

1998
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Animals; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Drug Administration Schedule; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Liver; Marmota; Skin Pigmentation; Viremia; Virus Replication; Zalcitabine

2001
Antiretroviral drug resistance.
    AIDS clinical care, 1995, Volume: 7, Issue:8

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Viremia; Zalcitabine; Zidovudine

1995
Conference looks at HIV drug resistance.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9

    Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine

1995
Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
    Intervirology, 1989, Volume: 30 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Animals; Cats; Cell Line; Cytopathogenic Effect, Viral; Delayed-Action Preparations; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Implants; Drug Therapy, Combination; Immunologic Deficiency Syndromes; Injections, Intravenous; Injections, Subcutaneous; Leukemia Virus, Feline; Leukemia, Experimental; Retroviridae Infections; Specific Pathogen-Free Organisms; Tetrahydrouridine; Viremia; Zalcitabine

1989